These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30215721)

  • 21. Optimal vancomycin dosing regimens for critically ill patients with acute kidney injury during continuous renal replacement therapy: A Monte Carlo simulation study.
    Charoensareerat T; Chaijamorn W; Boonpeng A; Srisawat N; Pummangura C; Pattharachayakul S
    J Crit Care; 2019 Dec; 54():77-82. PubMed ID: 31394493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
    Barth RH; DeVincenzo N
    Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.
    Liu TT; Pang HM; Jing L; Wei WX; Qin XL; Guo Q; Lu H; Cheng DH; Jiang WZ
    J Pharm Pharmacol; 2019 Jun; 71(6):945-955. PubMed ID: 30873627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.
    Decker BS; Kays MB; Chambers M; Kraus MA; Moe SM; Sowinski KM
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):1981-7. PubMed ID: 20616157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
    Brown DL; Lalla CD; Masselink AJ
    Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants.
    Jacqz-Aigrain E; Leroux S; Thomson AH; Allegaert K; Capparelli EV; Biran V; Simon N; Meibohm B; Lo YL; Marques R; Peris JE; Lutsar I; Saito J; Nakamura H; van den Anker JN; Sharland M; Zhao W
    J Antimicrob Chemother; 2019 Aug; 74(8):2128-2138. PubMed ID: 31049551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.
    Moffett BS; Morris J; Munoz F; Arikan AA
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
    Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
    J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Monte Carlo simulation to evaluate the development of vancomycin resistance in meticillin-resistant Staphylococcus aureus.
    Mei Q; Ye Y; Zhu YL; Cheng J; Yang HF; Liu YY; Li HR; Li JB
    Int J Antimicrob Agents; 2015 Jun; 45(6):652-6. PubMed ID: 25813394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC
    Issaranggoon Na Ayuthaya S; Katip W; Oberdorfer P; Lucksiri A
    Int J Infect Dis; 2020 Mar; 92():151-159. PubMed ID: 31935538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
    Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
    Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections.
    Hamada Y; Kuti JL; Nicolau DP
    J Antimicrob Chemother; 2015 Jul; 70(7):2064-7. PubMed ID: 25802284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An updated vancomycin dosing protocol for initiating therapy in patients undergoing intermittent high-flux hemodialysis.
    Zelenitsky SA; Ariano RE
    Am J Health Syst Pharm; 2022 Jun; 79(12):1006-1010. PubMed ID: 35234825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.